To examine the possible roles of mast cells in the pathogenesis of subcapsular cell hyperplasia (SCH) in the adrenal glands of mice, we investigated the expression of certain cytokines, including stem cell factor (SCF), tumor necrosis factor-alpha (TNF-&alpha;), nerve growth factor (NGF), and basic fibroblast growth factor (bFGF), and mast cell-specific proteases, such as mouse mast cell protease (mMCP)-2 and mMCP-7. The mRNAs of c-kit (SCF receptor), bFGF, TNF-&alpha;, mMCP-2, and mMCP-7 were expressed in both the adrenal glands and the mouse bone marrow-derived mast cells (mBMMCs). Immunoreactivities for cytokines (SCF, NGF, TNF-&alpha;) and proteases (mMCP-2, mMCP-7) were exclusively located in the mast cells in SCH lesions. The immature mBMMCs did not express the mRNAs of SCF and NGF, whereas the mast cells in the SCH lesions showed the expression of SCF and NGF. These findings suggest that SCH may provide a favorable microenvironment for functional maturation of mast cells to produce SCF and NGF, and the mast cells in SCH lesions synthesize SCF and NGF and may, in part, use them in autocrine fashion for their survival and differentiation. Therefore, mast cells may contribute to SCH pathogenesis by producing a range of multifunctional cytokines and proteases.
INTRODUCTION
Mast cells are widely distributed in tissues throughout the body, particularly in association with blood or lymphatic vessels and nerves and in genitourinary, gastrointestinal, and respiratory tracts and skin, which interface the external environment (1, 16, 46) . Mast cells are one of the major effector cells in the pathogenesis of allergic diseases and in certain host response to parasites, and IgE-dependent mast cell activation represents a central pathogenic event in such conditions (17, 24) . Mast cells also participate in a much broader spectrum of biologic process, including wound healing, angiogenesis, pathologic fibrosis, and host reaction to certain neoplasms, in which IgE has no demonstrable role (9, 30, 45) . Subcapsular cell hyperplasia (SCH) in the adrenal cortex is a common incidental finding in older mice of many strains but is rarely observed in young mice (15, 23) . Gonadectomy enhances the development of SCH at an early age and the severity of the lesion in both males and females (12, 13, 58) , but the etiology of SCH is not known. In the adrenal glands of mice, mast cells are closely associated with SCH in many strains (37) , and a significant correlation between the number of mast cells and the severity of SCH has been confirmed (36) . Mast cells may play an active part in the pathogenesis of SCH because they are an important source of a variety of preformed and newly synthesized mediators such as histamine, heparin, protease, and multifunctional cytokines (18, 54) , many of which have potential to affect the connective tissue microenvironment (24, 50) . However, specific functional roles of mast cells in the development of the SCH lesion have not yet been demonstrated. To better understand the role of mast cells in SCH, we investigated the expression of mRNAs and proteins of certain cytokines and mouse mast cell-specific proteases in the adrenal glands. For comparison, we also examined the expressions of such mRNAs in the mouse bone marrowderived mast cells (mBMMCs), which are believed to be progenitors of mast cells found in tissues (39, 48) .
MATERIALS AND METHODS
Animals. Ten-month-old female IQI/Jic mice maintained in the Laboratory Animal Facility of the National Institute of Industrial Health (Kawasaki, Japan) were kept in a controlled environment (22°C ± 2°C with 55% ± 5% relative humidity and 12-hr light/dark cycle) and given food (CE-2, Clea, Tokyo, Japan) and tap water ad libitum.
WEHI-3 Conditioned Medium. WEHI-3 cells were cultured (1 X 105 cells/ml) for 48 hours in enriched RPMI medium (RPMI-1640 supplemented with 2 mM L-glutamine, 50 f.1g/ml 2-mercaptoethanol, 0.1 mM nonessential amino acids, 100 U/ml penicillin, 100 >g/ml streptomycin, and 10% heat-inactivated fetal calf serum). The WEHI-3 conditioned medium was centrifuged for 10 minutes at 1,000 X g, and the supernatant was filtered through a 0.2-J.1m sterile filter before storage at -80°C.
This medium was used as a source of interleukin-3 (IL-3). Isolation and Culture of mBMMCs. mBMMCs were obtained by culturing bone marrow cells from the femurs and tibias of 10-month-old female IQI/Jic mice for 7 weeks in complete RPMI medium (50% enriched RPMI medium and 50% WEHI-3 conditioned medium). The cells were cultured at 37°C in a humidified atmosphere containing 5% CO,. At 3or 4-day intervals, the nonadherent cells were transferred into fresh complete RPMI medium in a new culture flask. The purity of mast cells was determined by staining with acid toluidine blue or alcian blue/safranin. After 7 weeks in culture, a homogeneous population of mBMMCs was obtained.
Reverse transcription polymerase chain reaction. Total RNA was extracted from the adrenal glands of 6 mice and from the mBMMCs using ISOGEN (WAKO, Japan). The cDNA was synthesized from total RNA using oligo(dT) primers and reverse transcriptase (Superscript, Life Technologies, Japan). The cDNA was amplified by polymerase chain reaction (PCR) in the presence of a master mix containing the PCR buffer, MgCl,, 2.5 U Taq DNA polymerase (AmpliTaq Gold, Perkin Elmer, Japan), 0.2 mM dNTPs, and specific primer pairs listed in Table  1 . PCR was conducted for 35 cycles under the following conditions: denaturation at 95°C for 60 seconds, annealing at 59°C for 60 seconds, and extension at 72°C for 90 seconds in a thermocycler (Takara, Japan). Final extension was at 72°C for 10 minutes. The PCR products were run on a 1 % agarose gel and stained with ethidium bromide. The identities of the PCR products, all of which migrated according to their predicted size, were confirmed by restriction enzyme digestion, which resulted in predicted fragment sizes. Tissue Processing. Adrenal glands of 10-month-old female IQI/Jic mice were removed and fixed with 4% paraformaldehyde in sodium phosphate buffer (0.1 M, pH 7.4) for 4 hours at 4°C. Specimens were washed twice with phosphate-buffered saline (PBS) containing 2% dimethyl sulfoxide and then were suspended in 50 mM NH,CL overnight at 4°C. The specimens were dehydrated and embedded in glycolmethacrylate (GMA) in accordance with the JB-4 embedding kit instructions (Polysciences, Warrington, PA, USA). Sections were cut on a Reichert-Jung Supracut microtome (Leica, Deerfield, IL, USA) with glass knives and transferred to glass slides. Histology and Immunohistochemistry. To identify and differentiate mast cells and other cells (eg, eosinophils) in a single tissue section, 2-f.1m-thick GMA tissue sections of the adrenal glands of 12 mice were stained sequentially with eosin-toluidine blue-hematoxylin (ETH). Additional tissue sections were stained in a single solution of toluidine blue or a mixed solution of alcian blue/ safranin (36) . For immunohistochemical examinations, GMA tissue sections of 6 mice were stained with immunoalkaline phosphatase, with some modifications of the previously described procedures (21, 22) . Tissue sections were washed and incubated sequentially for 15 minutes at 37°C in 2 mM CaCl2 containing 0.025% trypsin (pH 6.8), for 15 min at room temperature in PBS containing 0.05% Tween-20 and 0.1% bovine serum albumin, for 30 minutes at 37°C in PBS containing 0.05% Tween-20 and 4% normal goat serum, and then overnight at 4°C in 4% normal goat serum containing one of the following antibodies: rabbit polyclonal anti-mouse stem cell factor (SCF, 1:100; Genzyme, Cambridge, MA, USA), rat monoclonal anti-mouse c-kit (1:100; Pharmingen, San Diego, CA, USA), mouse anti-bovine basic fibroblast growth factor (bFGF, 1:100; Upstate Biotechnology, Lake Placid, NY, USA), rabbit anti-mouse nerve growth factor (NGF, 1:1,000; Chemicon International, Temecula, CA, USA), rabbit anti-mouse tumor necrosis factor alpha ( counterstained with methyl green, washed, dried, and then mounted. Controls consisted of sections of tissue from 5 different mice treated with nonimmune IgG (Endogen) or without primary antibody. Figure 1 shows the expression of mRNAs of cytokines and proteases in the adrenal glands and mBMMCs. Histologically, all of the IQI/Jic mice used in this study showed SCH in the adrenal cortex. Only 1 mouse showed SCH unilaterally in adrenal gland; all other mice showed the lesions in bilateral adrenal glands. Mast cell accumulations were observed in the SCH lesion, but no other inflammatory cell infiltrate was observed (Figure 2A ).
RESULTS
Mast cells were not detected in the medulla nor in the intact adrenal cortex. IL-3-dependent cultured mBMMCs showed the cytochemical characteristics of immature mast cell phenotype, that is, alcian blue+/safranin-/berberine sulfate-(data not shown).
SCF and c-kit
The expression of mRNA of c-kit was detected in both the mBMMCs and the adrenal glands. Although the mRNA of SCF (c-kit ligand) was expressed in the adrenal glands, it was not detected in the mBMMCs. Immunoreactivity for both SCF and c-kit was observed in the mast cells in the adrenal glands ( Figure 2B , C). Table 2 summarizes the expression patterns of cytokines and proteases in the mBMMCs and adrenal glands of IQI/Jic mice.
TNF-a
The mRNA of TNF-a was expressed in both the mBMMCs and the adrenal glands. Immunoreactivity for TNF-cx was observed in the SCH lesion, and positive staining was located in the mast cells ( Figure 2D) . NGF Although the mRNA of NGF was not expressed in the mBMMCs, it was detected in the adrenal glands. Strong immunostaining for NGF was localized to mast cells in the adrenal glands (Figure 2E ). bFGF The mRNA of bFGF was expressed in both the m-BMMCs and the adrenal glands. Immunohistochemically, bFGF-positive staining was not observed in the adrenal glands ( Figure 2F ).
mMCP-2 and mMCP-7
The mRNA expressions of mMCP-2 and mMCP-7 were detected in both the mBMMCs and the adrenal glands. Mast cells in the SCH lesions showed strong immunoreactivity for mMCP-2 or mMCP-7 ( Figure 2G , H).
DISCUSSION
We have previously shown that mast cells are closely associated with SCH in the adrenal cortex in several strains of mice (37) and confirmed the positive correlation between the number of mast cells and the severity of SCH lesions in IQI/Jic mice (36) . Although the mast cells present in the SCH lesions exhibited mixed phenotype, ie, containing both safranin+/berberine sulfate+ and alcian blue+lberberine sulfategranules, the majority of the mast cells showed mature phenotype as judged by staining of the cytoplasmic granules with heparin-binding dye berberine sulfate (36) . Thus, the local environment in the SCH lesions might lead to marked accumulation and maturation of mast cells, and these effects might reflect the continuous local production of mast cell growth/ maturation factors in the SCH lesions.
Mast cell accumulation in the tissues appears to depend on the homing of bone marrow-derived mast cell precursors into the tissues and the subsequent induction of their growth and differentiation (17) . In the case of mast cells in the SCH lesions of mouse adrenal glands, the production of factor(s) by hyperplastic subcapsular cells could induce migration of mast cell precursors. Although the expression of SCF protein could not be detected on the hyperplastic subcapsular cells by the staining technique applied, SCF could be an excellent candidate for such a factor because the SCF acts as an adhesion receptor for c-kit+ mast cell progenitors (2) , and the signals generated by binding of the SCF to the c-kit receptor tyrosine kinase is essential for the development of mast cells (20, 38, 56, 59) . In addition, SCF has been known to stimulate the adhesion of mast cells to connective tissue matrix components by activating mast cells through its interaction with c-kit (11) , and SCF is produced by several cell types including endothelial cells, stromal cells in bone marrow (3) , and fibroblasts in tissues (57) . One possible reason for the failure to detect SCF on hyperplastic cells is that this protein might be expressed in lower amounts than can be detected by the immunohistochemistry method used.
In this study, the expressions of mRNAs of both c-kit and SCF were detected in the adrenal glands of mice, whereas the mRNA of SCF was not detected in the FIGURE 2.-Immunohistochemistry of mast cells found in SCH lesions in the adrenal glands of IQI/Jic mice. GMA tissue sections were stained with ETH to identify the infiltrated cells (A) and evaluated immunohistochemically with anti-mouse SCF (B), anti-mouse c-kit (C), anti-mouse TNF-a (D), anti-mouse NGF (E), anti-bovine bFGF (F), anti-mouse mMCP-2 (G), and anti-mouse mMCP-7 (H). mBMMCs. Moreover, the mast cells infiltrating the SCH lesions expressed the SCF protein as well as c-kit. The observation that tissue mast cells express c-kit was an expected finding because c-kit is detectable on mast cells and on mast cell progenitor cells. However, mast cells present in the SCH lesions express the SCF protein. This observation suggests that infiltrating mast cells in the SCH lesions may synthesize SCF and use it in an autostimulatory loop for development and survival; SCF is a major and critical growth factor supporting survival and development of both murine and human mast cells (19, 20, 55) , and SCF is known to prevent mast cell apoptosis (34) .
TNF-a is a cytokine with a wide variety of biologic activities that include the ability to activate various cell populations (polymorphonuclear leukocytes, lymphocytes, endothelial cells, and fibroblasts) and to stimulate the production of other mediators (53) . Both freshly isolated mouse serosal mast cells and in vitro-derived mouse mast cells produce TNF-a (25, 26) . Recent studies demonstrated that TNF-a promotes collagen gene expression (27) and proliferation of mouse fibroblasts (35) and stimulates DNA synthesis and proliferation of human fibroblasts (4) . Hyperplastic subcapsular cells actively synthesize collagen fibrils (Kim et al, submitted) , and the mast cells infiltrating the SCH lesions produce TNF-cx; thus, it seems reasonable to hypothesize that mast cells may contribute to SCH pathogenesis by stimulating hyperplastic subcapsular cells.
Although NGF does not stimulate the growth of murine mast cell colonies when added alone to cultures, it does induce a phenotypic change in IL-3-dependent mBMMCs with an increase in heparin synthesis (43) , suggesting that NFG may support the differentiation of connective tissue-type mast cells. NGF also enhances survival of mast cells (31) and prevents apoptosis of connective tissue-type mast cells (34) . Although the expression of NGF mRNA was not detected in the mBMMCs, the production of NGF protein was observed in the mast cells infiltrated in the SCH lesions. These findings indicate that mast cells infiltrated in the SCH lesions produce NGF and may use it in an autocrine fashion for survival and development. bFGF is a potent mitogenic and chemotactic factor for cells of mesodermal, ectodermal, and endodermal origin (28, 29) , including fibroblasts, smooth muscle cells, and alveolar type II cells (41, 42) . The role of bFGF as an angiogenic factor is well established (6, 28, 40, 49) . Re-cent studies suggest that human mast cells are potential source of bFGF in normal skin and lungs and in tissue samples characterized by fibrosis and neovascularization (33, S 1 ) . bFGF has high affinity to heparin (14) and tissue resident mast cells in the SCH lesions contain abundant heparin (36) ; thus, these mast cells may contain bFGF However, despite the expression of bFGF mRNA in both the mBMMCs and the adrenal glands, immunostaining for bFGF was not detected in the adrenal glands. It may be that an immunohistochemically undetectable level of bFGF was produced by infiltrating mast cells in the SCH lesions.
Although many mast cell-associated mediators are produced by other cell types, the granule-associated neutral proteases (chymase and tryptase) may represent constituents restricted to mast cells. Depending on their tissue locations, mouse mast cells express various combinations of neutral proteases. The proteases mMCP-1-5 are highly homologous chymases, and mMCP-6 and mMCP-7 are tryptases (21, 32, 44) . Tryptase can alter cell behavior. For example, tryptase is a potent growth factor for a number of cell types, including fibroblasts (8, 52) , epithelial cells (7) , and airway smooth muscle cells (5) , and is able to stimulate vascular tube formation in dermal microvascular endothelial cells (10) . Although the information concerning the actions of chymase is limited, the expression of chymase by human mast cells is associated with cell development and differentiation (51) . Because mast cell enzymes modulate various tissue functions (47) , the findings that strong immunoreactivities for mMCP-2 (chymase) and mMCP-7 (tryptase) were found in the mast cells in the SCH lesions may help to explain the association of mast cells with SCH if there is a causal relationship.
We found that the mast cells infiltrated in the SCH lesions of mouse adrenal glands produced and stored a range of cytokines (SCF: NGF, and TNF-a) and mast cellspecific proteases (mMCP-2 and mMCP-7). Although the bone marrow-derived immature mast cells did not express the mRNAs of SCF and NGF, the mast cells in the SCH lesions showed the expression of SCF and NGF These findings led to the hypothesis that SCH might provide a favorable microenvironment for mast cell differentiation and maturation, and tissue mast cells in SCH lesions synthesize SCF and NGF and might use them in an autocrine fashion for survival and differentiation. Although the etiology of SCH remains unclear, the results of the present study lead to several hypotheses. Mast cells may contribute to SCH pathogenesis in the adrenal glands of mice by producing a range of multifunctional cytokines and proteases. Also, the bidirectional interactions between mast cells and hyperplastic subcapsular cells and the autostimulatory loops of mast cells may provide an explanation for the association of continuous mast cell accumulation with the persistent character of the SCH in the adrenal glands of mice. Kyuwa (Department of Animal Pathology, Institute of Medical Science, University of Tokyo) for providing WEHI-3 cells.
